Canadian drug company's FM strategy is far from generic

When a system failure occurred on a weekend upon restarting after a scheduled power outage, the manufacturer was able to source replacement parts and restore operations by noon on Monday, thanks to JLL’s help.

The generic pharmaceuticals industry is robust and growing, with some estimates predicting that the global market will exceed $500 billion by the end of 2028. For one Canadian manufacturer of generic cold and flu medicines, nasal sprays and other drugs, demand for these products has spurred business growth, which increased the complexity involved in managing the company’s facilities. In 2019, the company determined that the time had come to seek the support of a dedicated and experienced facilities management partner—enter JLL.

While this pharma company was expanding its facilities to support the growth of the business, it faced significant market pressure on generic drug pricing. The company needed to maximise the efficiency of its facilities management (FM) operations, especially when it came to managing vendor relationships and other expenses.

This company had never trusted the critical function of keeping its facilities running smoothly to a third party. But leadership also recognised during this growth period that an experienced partner with innovative ideas, sophisticated tools and a fresh perspective could both address short-term challenges and help set their business up for long-term success.